Pacific Biosciences CEO and COO swap interim responsibilities effective Jan 28, 2026

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

CEO Christian Henry assumes interim oversight of operations and R&D from COO Mark Van Oene.
COO Mark Van Oene assumes interim oversight of sales and customer support from CEO Christian Henry.
No changes to titles or compensation for either executive as a result of the reassignment.
Effective date of role adjustment: January 28, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.